Amgen Inc. buy Argus
Start price
17.10.23
/
50%
€269.00
Target price
17.10.24
€293.01
Performance (%)
-1.97%
Price
02.05.24
€259.65
Summary
This prediction is currently active. With a performance of -1.97%, the BUY prediction by Argus is trending in the wrong direction. Dividends of €4.05 are taken into consideration when calculating the performance. This prediction currently runs until 17.10.24. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 3.384% | 3.384% |
| iShares Core DAX® | 0.000% | -2.064% |
| iShares Nasdaq 100 | 0.626% | -2.884% |
| iShares Nikkei 225® | 1.568% | -5.892% |
| iShares S&P 500 | 0.334% | -2.281% |
Comments by Argus for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Argus from $280.00 to $310.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat